Vitramyn Tablet
NDC Package 59088-193-54
Package Information
Vitramyn (folic acid) tablets is folic acid is the man-made form of folate. This formulation utilizes a tablet delivery system. Marketed by Puretek Corporation, this product is identified by NDC 59088-193.
Identification & Billing
Clinical Specifications
- RIBOFLAVIN 30 mg/1
- NIACINAMIDE 120 mg/1
- ASCORBIC ACID 200 mg/1
- FOLIC ACID 20 ug/1
- CYANOCOBALAMIN 35 ug/1
- CALCIUM CARBONATE 8 ug/1
- VITAMIN A ACETATE 1000 ug/1
- THIAMINE MONONITRATE 200 mg/1
- ZINC OXIDE 2.3 mg/1
- MANGANESE SULFATE 45 ug/1
- .ALPHA.-TOCOPHEROL ACETATE, DL- 20 mg/1
- MAGNESIUM OXIDE 20 mg/1
- CHROMIUM NICOTINATE 3.4 mg/1
- PYRIDOXINE HYDROCHLORIDE 55 ug/1
- MOLYBDENUM 3 mg/1
- SELENIUM 1500 ug/1
- CHOLECALCIFEROL 25 mg/1
- Analogs/Derivatives - [Chemical/Ingredient]
- Ascorbic Acid - [CS]
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cations, Divalent - [CS]
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vitamin A - [CS]
- Vitamin A - [EPC] (Established Pharmacologic Class)
- Vitamin B 12 - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B12 - [EPC] (Established Pharmacologic Class)
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
- Vitamin C - [EPC] (Established Pharmacologic Class)
- Vitamin D - [CS]
- Vitamin D - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 59088 - Puretek Corporation
- 59088-193 - Vitramyn
- 59088-193-54 - 30 TABLET in 1 BOTTLE, PLASTIC
- 59088-193 - Vitramyn
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59088-193-54 identifies a specific commercial package of 30 tablet in 1 bottle, plastic of Vitramyn, a human prescription drug labeled by Puretek Corporation. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet is formulated for oral use and contains riboflavin; niacinamide; ascorbic acid; folic acid; cyanocobalamin; calcium carbonate; vitamin a acetate; thiamine mononitrate; zinc oxide; manganese sulfate; .alpha.-tocopherol acetate, dl-; magnesium oxide; chromium nicotinate; pyridoxine hydrochloride; molybdenum; selenium; cholecalciferol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Puretek Corporation on August 20, 2021. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Folic acid is the man-made form of folate. Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects.
How is this Puretek Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59088019354. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.